DaVita is a leading provider of kidney care services in the United States. Established in 1999, the company is headquartered in Denver, Colorado. The name DaVita is derived from Italian and means giving life.

Initially, DaVita was a part of Total Renal Care, a dialysis provider that merged with Gambro Healthcare in 1996. In 1999, Total Renal Care adopted the name DaVita and began trading on the New York Stock Exchange. DaVita quickly expanded through acquisitions and partnerships, becoming one of the largest kidney care providers in the country.

DaVita offers a range of services including dialysis treatment, kidney transplant support, and related laboratory and pharmacy services. Dialysis treatment is the primary focus for the company, providing hemodialysis, peritoneal dialysis, and home dialysis options to patients with chronic kidney disease or end-stage renal disease. DaVita also emphasizes patient education and support with various programs aimed at improving quality of life and reducing hospitalizations.

While DaVita primarily operates in the United States, the company has a global presence. It has subsidiary operations in many countries, including Germany, Poland, Brazil, Colombia, and China. DaVita also engages in joint ventures and partnerships to expand its reach.

One notable joint venture is with Shanghai Henlius Biotech, a Chinese biopharmaceutical company, to develop and sell biosimilar drugs. In terms of market position, DaVita is a leader in the kidney care sector. With approximately 2,800 dialysis centers in the United States and over 250 centers internationally, the company serves more than 220,000 patients worldwide.

DaVita faces competition from other dialysis providers such as Fresenius Medical Care. In recent years, DaVita has experienced several significant events and achievements. In 2018, the company sold its DaVita Medical Group subsidiary to UnitedHealth Group, allowing it to focus exclusively on kidney care services.

Additionally, DaVita has made efforts to expand its home dialysis program, aiming to provide more patients with the option to receive treatment in the comfort of their own homes. As of the latest information available, DaVita continues to be a prominent player in the kidney care industry. The company remains dedicated to providing high-quality care and improving patient outcomes.

DaVita's commitment to innovation and patient-centered care positions it well for future growth and success